Value through Innovation27 July 2016

What is a lay summary?

To view this video in other translations click on the language below:
Chinese (simplified)
Chinese (traditional)
French
German
Italian
Japanese
Portuguese (Brazilian)
Spanish

Clinical Study Results

  • Diclofenac + Capsaicin - Pain
    Clinical Study Number 1358.1
    Study Indication Pain
    Product Diclofenac + Capsaicin
    Generic Name Diclofenac + Capsaicin
    Lab Code
    Clinical Phase III
    Study Title

    A randomised, controlled multi-centre parallel group study to assess the efficacy and safety of multiple doses of a topically applied combination containing diclofenac 2% + capsaicin 0.075% (2 g formulation per application; 2-times daily for 5 days) compared to placebo, as well as to diclofenac 2% and capsaicin 0.075% in patients with acute back or neck pain

    Study Document
    Trial synopsis 1358.1 english
  • Diclofenac + Capsaicin - Pain
    Clinical Study Number 1358.2
    Study Indication Pain
    Product Diclofenac + Capsaicin
    Generic Name Diclofenac + Capsaicin
    Lab Code
    Clinical Phase I
    Study Title

    A Single Center, Multiple-Dose, Open-Label, Randomized, Three-Period Crossover Study To Determine The Relative Bioavailability Of Diclofenac In The Topical Gel Combination Product (Diclofenac 2% + Capsaicin 0.075%) Compared To Diclofenac Mono Gel 2% And Voltarol® 12 Hour Emulgel 2.32% Gel In At Least 42 Healthy Males And Females

    Study Document
    Trial synopsis 1358.2 english